Our corporate responsibility strategy focuses on creating comprehensive and sustainable solutions that can be replicated and scaled up locally, nationally and globally. Yet we recognize the vital role philanthropic giving and product donations play in improving access to our medicines for people around the world.
In the United States, we provide access to our medicines for eligible patients through Lilly Cares, our established patient-assistance programs. Outside of the United States, we work through multiple partnerships on a number of efforts to reach people in need, including:
Life for a Child
Lilly has committed to donating nearly 1.6 million vials of insulin to the International Diabetes Federation’s Life for a Child program—one of our largest single product donations. As of August 2014, the IDF’s program provided support to nearly 14,000 children and youth with diabetes in 46 of the world’s poorest countries.
As part of this effort, Lilly partnered with the IDF to produce Life for a Child and In the Hearts of Africa, two documentaries featuring the journeys of children with type 1 diabetes in Nepal and the Democratic Republic of Congo, respectively. Through providing a glimpse into the world of these children, we hope to raise awareness of the devastating impact of diabetes and increase support for the Life for a Child program.
Our more than 10-year partnership with Indiana University and the Moi Teaching and Referral Hospital provides donations and medicines to treat diabetes, mental illness and cancer. Through the AMPATH (Academic Model Providing Access to Healthcare) program, Indiana University and Moi Staff collaborate to improve patient outcomes. Since 2002, we’ve donated about $60 million in medicines. In early 2015, the Lilly Foundation provided a $1 million grant to support AMPATH’s Oncology Institute efforts to screen, treat, and provide palliative care to people living in low income communities who are fighting cancer.
When disasters strike, we respond with cash and product contributions to help people in desperate situations. Every disaster is different, prompting a wide variety of needs. When responding, we take great care not to overburden the local infrastructure, so that our product donations are meaningful and have the greatest impact. We donate items that are specifically requested by relief agencies, partnering with them to best leverage our support.
We also join with the Partnership for Quality Medical Donations (PQMD), which brings together international medical product companies and humanitarian organizations to advance the quality of product donations through standards, education and research. Lilly is a charter member of PQMD—which officially incorporated in 2000—and one of our employees sits on the PQMD executive committee.
One of our biggest product donation efforts followed the devastating earthquake in Haiti in January 2010. We sent insulin and antibiotics—items that are critically needed following any disaster. Our support for Haiti’s recovery also included a grant by the Lilly Foundation to fund the transportation of two self-contained medical clinics from the United States to rural Haitian villages.